ENSC
NASDAQ
$0.29
Ensysce Biosciences Inc (ENSC)
Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. The company is headquartered in La Jolla, California.
Sector:
Healthcare
Industry:
Biotechnology
Target: $16.45 (+5645.72%)
Market Cap
$2.88M
P/B Ratio
0.85
Revenue 5Y CAGR
+79.79%
FCF 5Y CAGR
+61.09%
Price Chart
Valuation
Market Cap$2.88M
Forward P/E0.95
P/S0.61
P/B0.85
Profitability
Total Revenue (TTM)$4.71M
Gross Profit (TTM)-$7.13M
EBITDA-$12M
Profit Margin-250.4%
Operating Margin-370.7%
EPS-$2.89
Growth & Risk
Revenue 5Y CAGR+79.79%
FCF 5Y CAGR+61.09%
Sharpe Ratio-1.24